유방의 침윤성 유관암에서 cyclin D1, bcl-2의 발현: 그 연관관계와 임상적 의미 = Expression of Cyclin D1 and bcl-2 in Infiltrative Ductal Carcinoma of the Breast: Their Correlations and Clinical implications

다국어 초록 (Multilingual Abstract)

Purpose: Cyclin D1 and bcl-2 are involved in cell proliferation and apoptosis in tumor development and are commonly expressed in breast cancer. But there are few clinical reports on the correlation between cyclin D1 and bcl-2 expression. This study was designed to analyze the correlations of cyclin D1 and bcl-2 and their clinical implications in breast cancer. Methods: Immunohistochemical expression of cyclin D1 and bcl-2 were studied in 342 infiltrative ductal carcinoma cases and were compared with clinicopathologic parameters such as age, tumor size, histologic grade, lymph node status,
p53, c-erbB2 and hormone receptors. Results: Cyclin D1 expression was found in 86 of 342 cases (25.1%). Bcl-2 was positive in 227 of 342 cases (66.4%). Bcl-2 overexpression was associated with the high expression of
cyclin D1 (p=0.001). Correlation was detected between both cyclin D1 and bcl-2 and hormone receptor positivity (p<0.001). There was a reverse correlation between bcl-2 and histologic grade, p53, c-erbB2. And the bcl-2 overexpression group showed better disease free survival rates at 3-year follow up. Conclusion: Higher expression of cyclin D1 was associated with bcl-2 overexpression. Positive estrogen receptor expression was associated with high cyclin D1 and bcl-2 expression. Bcl-2 tends to correlate with a positive clinical outcome.

참고문헌 (Reference)

1 Zhang G, "Value of cancer-related oncoprotein expression as prognostic factors in breast cancers with one to three axillary lymph nodes positive" 23 : 66-74, 1996

2 Joensuu H, "Toikkanen S. Bcl-2 protein expression and long-term survival in breast cancer" 145 : 1191-1198, 1994

3 Silvestrini R, "The bcl-2 protein: a prognostic indicator strongly related to p53 protein in lymph node-negative breast cancer patients" 86 : 499-504, 1994

4 Lim SC, "Role of COX-2, VEGF and cyclin D1 in mammary infiltrating duct carcinoma" 10 : 1241-1249,

5 Hwang TS, "Prognostic value of combined analysis of cyclin D1 and estrogen receptor status in breast cancer patients" 53 : 74-80, 2003

6 Hellemans P, "Prognostic value of bcl-2 expression in invasive breast cancer" 72 : 354-360, 1995

7 Dowdy SF, "Physical interaction of the retinoblastoma protein with human D cyclins" 73 : 499-511, 1993

8 Zhang SY, "Immunohistochemistry of cyclin D1 in human breast cancer" 102 : 695-698, 1994

9 Gee JM, "Immunocytochemical localization of bcl-2 protein in human breast cancers and its relationship to a series of prognostic markers and response to endocrine therapy" 59 : 619-628, 1994

10 Musgrove EA, "Growth factor steroid and steroid antagonist regulation of cyclin gene expression associated with changes in T-47D human breast cancer cell cycli progression" 13 : 3577-3587, 1993

11 Arykok AT, "Expressions of cyclin D1, p53, bcl-2, and bax in infiltrative ductal carcinoma of the breast: correlations with clinicopathologic characteristics" 391 (391): 2006

12 Kang HJ, "Expression of p53, c-erbB2, bcl-2, cathepsin D in infiltrating ductal carcinoma of the breast" 4 : 144-151, 2001

13 Wang TT, "Effects of estrogen on apoptotic pathways in human breast cancer cell line MCF-7" 55 : 2487-2489, 1995

14 Lebeau A, "EGFR, HER-2/neu, cyclin D1, p21 and p53 in correlation to cell proliferation and steroid hormone receptor status in ductal carcinoma in situ of the breast" 79 : 187-198, 2003

15 Park SH, "Down regulation of bcl2 expression in invasive ductal carcinomas is both estrogen- and progesterone-receptor dependent and associated with poor prognostic factors" 8 : 26-30, 2002

16 Haldar S, "Down regulation of bcl-2 by p53 in breast cancer cells" 54 : 2095-2097, 1994

17 van Diest PJ, "Cyclin D1 expression in invasive breast cancer. Correlations and prognostic value" 150 : 705-711, 1997

18 Bartkova J, "Cyclin D1 expression and function in human breast cancer" 57 : 353-361, 1994

19 Zukerberg LR, "Cyclin D1 (PRAD1) protein expression in breast cancer: approximately one-third of infiltrating mammary carcinomas show everexpression of the cyclin D1 oncogene" 8 : 560-567, 1995

20 Lu QL, "Bcl-2: role in epithelial differentiation and oncogenesis" 27 : 102-110, 1996

21 Pezzella F, "Bcl-2 protein in non-small-cell lung carcinoma" 329 : 690-694, 1993

22 Hurlimann J, "Bcl-2 protein in invasive ductal breast carcinomas" 426 : 163-168, 1995

23 Lin HM, "Bcl-2 induces cyclin D1 promoter activity in human breast epithelial cells independent of cell anchorage" 8 : 44-50, 2001

24 Leek RD, "Bcl-2 in normal human breast and carcinoma, associated with estrogen receptorpositive, epidermal growth factor-negative tumors and in situ cancer" 69 : 135-139, 1994

25 Tsujimoto Y, "Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in humjan follicular lymphoma" 83 : 5214-5218, 1986

26 Michalides R, "A clinicopathological study on overexpression of cyclin D1 and p53 in a series of 248 patients with operable breast cancer" 73 : 728-734, 1996